Related Experiment Video
Updated: May 15, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Ischemic cardiomyopathy: midterm survival and its predictors
Nigel Pinto1, Brian Haluska, Julie Mundy
1Department of Cardiothoracic Surgery, Princess Alexandra Hospital, Brisbane, Australia.
Myocardial revascularization improves heart function and survival in ischemic cardiomyopathy patients. Cerebrovascular disease and arrhythmias predict poorer outcomes after this procedure.
Area of Science:
- Cardiology
- Cardiac Surgery
Background:
- Ischemic cardiomyopathy significantly impacts long-term survival.
- Myocardial revascularization is a potential treatment option.
Purpose of the Study:
- To analyze all-cause mortality after myocardial revascularization for ischemic cardiomyopathy.
- To identify predictors of long-term survival in these patients.
Main Methods:
- Retrospective analysis of 101 patients with stable coronary artery disease and low ejection fraction (<30%).
- Data collected between April 2000 and June 2010.
- Follow-up averaged 56.3 months, with 97% completeness.
Main Results:
- Operative mortality was 1.9%.
- Left ventricular ejection fraction improved significantly post-surgery (25.99% to 34%, p <0.0001).
- 18.75% experienced late deaths; 10-year survival was 75%. Preoperative arrhythmia and cerebrovascular disease were linked to higher mortality.
Conclusions:
- Myocardial revascularization enhances left ventricular ejection fraction and offers favorable long-term survival in ischemic cardiomyopathy.
- Preoperative arrhythmias and cerebrovascular disease are critical factors associated with adverse outcomes.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy VI: Nursing Management
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis I: Introduction
